Advertisement

Somatostatin pp 425-445 | Cite as

Role of Somatostatin in Nutrient Regulation

  • V. Schusdziarra
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 188)

Abstract

Somatostatin-immunoreactive material has been found in D cells of the stomach, small intestine and pancreas (1–6); additionally, it is present in vagal nerve fibres and in neurons of the myenteric and submucosal plexus of the intestinal tract (7–9). Within the gastrointestinal tract and pancreas, an accumulation of D cells has been demonstrated in the fundic and antral area of the stomach and in the islets of Langerhans, whereas a more scattered distribution has been shown in the small and large intestine (10–12). This localization of somatostatin in organs which are exclusively responsible for adequate digestion, absorption and disposal of ingested nutrients raises the possibility that somatostatin might participate in the regulation of nutrient entry from the gastrointestinal tract into the circulation. Thus, somatostatin-containing D cells are in contact with nutrients at all stages of nutrient assimilation.

Keywords

Harris Versus Opiate Receptor Antagonist Naloxone Maier Versus Schusdziarra Versus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hökfelt T, Efendic S, Hellerström C, Johansson O, Luft R, Arimura A 1975 Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol 80 (Suppl 200): 5.Google Scholar
  2. 2.
    Orci L, Baetens D, Dubois MP, Rufener C 1975 Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res 7: 400.PubMedCrossRefGoogle Scholar
  3. 3.
    Polak JM, Grimelius L, Pearse AGE, Bloom SR, Arimura A 1975 Growth hormone release inhibiting hormone in gastrointestinal and pancreatic D-cells. Lancet 1: 1220.PubMedCrossRefGoogle Scholar
  4. 4.
    Luft R, Efendic S, Hokfelt T, Johansson O, Arimura A 1974 Immunohistochemical evidence for the localization of somatostatin-like immunoreactivity in a cell population of the pancreatic islets. Med Biol 52: 428.PubMedGoogle Scholar
  5. 5.
    Dubois MP 1975 Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci (USA) 72: 1340.CrossRefGoogle Scholar
  6. 6.
    Pelletier G, Leclerc R, Arimura A, Schally AV 1975 Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem 23: 699.PubMedCrossRefGoogle Scholar
  7. 7.
    Hokfelt T, Elfvin LG, Elde E, Schultzberg M, Goldstein M, Luft R 1977 Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. Proc Natl Acad Sci (USA) 74: 3587.CrossRefGoogle Scholar
  8. 8.
    Hokfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M 1980 Peptidergic neurons. Nature 284: 515.PubMedCrossRefGoogle Scholar
  9. 9.
    Uvnas-Wallensten K, Efendic S, Luft R 1978 Occurrence of somatostatin-like immunoreactivity in the vagal nerves. Acta Physiol Scand 103: 907.Google Scholar
  10. 10.
    Arimura A, Sato H, Dupont A, Nishi N, Schally AV 1975 Somatostatin: Abundance of immunoreactive hormone in rat stomach and pancreas. Science 89: 1007.Google Scholar
  11. 11.
    Kronheim S, Berelowitz M, Pimstone BC 1976 Radioimmunoassay for growth hormone release inhibiting hormone: method and qualitative tissue distribution. Clin Endocrinol 5: 619.CrossRefGoogle Scholar
  12. 12.
    Alumets J, Sundler F, Hakanson R 1977 Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tiss Res 185: 465.Google Scholar
  13. 13.
    Unger RH, Ipp E, Schusdziarra V, Orci L 1977 Hypothesis: Physiologic role of pancreatic somatostatin and the contribution of D-cell disorder to diabetes mellitus. Life Sci 20: 2081.Google Scholar
  14. 14.
    Taborsky GJ Jr, GJ 1983 Evidence of a paracrine role for pancreatic somatostatin in vivo. Am J Physiol 245: E598.PubMedGoogle Scholar
  15. 15.
    Schusdziarra V, Ipp E, Harris V, Dobbs RE, Raskin P, Orci L, Unger RH 1978 Studies of the physiology and pathophysiology of the pancreatic D-cell. Metabolism 27 (Suppl 1): 1227.PubMedCrossRefGoogle Scholar
  16. 16.
    Grube D, Bohn R 1983 The microanatomy of human islets of Langerhans with special reference to somatostatin cells. Arch Histol Jap 46: 327.PubMedCrossRefGoogle Scholar
  17. 17.
    Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger RH 1978 Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HC1 in the dog. J Clin Invest 62: 509.PubMedCrossRefGoogle Scholar
  18. 18.
    Schusdziarra V, Zyznar E, Rouiller D, Harris V, Unger RH 1980 Free somatostatin in the circulation: Amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic and vena caval plasma of fasting and meal-stimulated dogs. Endocrinology 107: 1572.Google Scholar
  19. 19.
    Berelowitz M, Kronheim S, Pimstone B, Shapiro B 1978 Somatostatin-like immunoreactivity in rat blood. J Clin Invest 61: 1410.PubMedCrossRefGoogle Scholar
  20. 20.
    Vinik AJ, Shapiro B, Glaser B, Wagner L 1981 Circulating somatostatin in primates. In: Bloom SR, Polak JM (eds) Gut Hormones. Churchill Livingstone, Edinburgh, p 371.Google Scholar
  21. 21.
    Schusdziarra V, Rouiller D, Harris V, Conlon JM, Unger RH 1978 The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs. Endocrinology 103: 2264.PubMedCrossRefGoogle Scholar
  22. 22.
    Chayvialle JA, Myata M, Rayford PL, Thompson JC 1980 Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vaso-active intestinal peptide in dogs. Gastroenterology 79: 844.PubMedGoogle Scholar
  23. 23.
    Wass JAH, Penman E, Dryburgh JR, Tsiolakis D, Goldberg PL, Dawson AM, Besser GM, Rees LH 1980 Circulating somatostatin after food and glucose in man. Clin Endocrinol 12: 569.CrossRefGoogle Scholar
  24. 24.
    Vinik AJ, Levitt NS, Pimstone B, Wagner L 1981 Peripheral plasma somatostatin-like immunoreactive responses to insulin hypoglycemia and a mixed meal in healthy subjects and in noninsulin-dependent maturity-onset diabetics. J Clin Endocrinol Metab 52: 330.PubMedCrossRefGoogle Scholar
  25. 25.
    Penman E, Wass JAH, Medbak S, Morgan L, Lewis JM, Besser GM, Rees LH 1981 Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81: 692.PubMedGoogle Scholar
  26. 26.
    Schusdziarra V, Rouiller D, Pietri A, Harris V, Zyznar E, Conlon JM, Unger RH 1979 Pancreatic and gastric release of somatostatin-like immunoreactivity during the intestinal phase of meal. Am J Physiol 273: 555.Google Scholar
  27. 27.
    Rouiller D, Schusdziarra V, Conlon JM, Harris V, Unger RH 1979 Release of somatostatin-like immunoreactivity from the lower gut. Gastroenterology 77: 700.PubMedGoogle Scholar
  28. 28.
    Schusdziarra V, Dangel G, Henrichs I, Klier M, Pfeiffer EF 1982 Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal. Horm Metab Res 14: 169.PubMedCrossRefGoogle Scholar
  29. 29.
    Schusdziarra V, Bender H, Torres A, Pfeiffer EF 1982 Dose-dependent inhibitory and non-inhibitory action of somatostatin on insulin release in rats. Regul Peptides 4: 147.CrossRefGoogle Scholar
  30. 30.
    Schusdziarra V, Rouiller D, Harris V, Unger RH 1979 Gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal. Effects of truncal vagotomy and atropine in the anesthetized dog. Diabetes 28: 658.Google Scholar
  31. 31.
    Schusdziarra V 1983 Somatostatin - physiological and pathophysiological aspects. Scand J Gastroenterol 18 (Suppl 82): 69.Google Scholar
  32. 32.
    Schusdziarra V, Rewes B, Lenz N, Maier V, Pfeiffer EF 1983 Evidence for a role of endogenous opiates in postprandial somatostatin release. Regul Peptides 6: 355.CrossRefGoogle Scholar
  33. 33.
    Lucey MR, Fairclough PD, Wass JAH, Penman E, Besser GM, Rees LH 1983 Is gastric acid a factor in post-prandial plasma somatostatin release in man? Gastroenterology 84: 61.Google Scholar
  34. 34.
    Schusdziarra V, Bender H, Pfeffer A, Pfeiffer EF 1984 Modulation of acetylcholine-induced secretion of gastric bombesinlike immunoreactivity by cholinergie and histamine H2-receptors, somatostatin and intragastric pH. Regul Peptides 8: 189.CrossRefGoogle Scholar
  35. 35.
    McIntosh C, Pederson R, Muller M, Brown J 1931 Autonomic nervous control of the gastric somatostatin secretion from the perfused rat stomach. Life Sci 29: 1477.CrossRefGoogle Scholar
  36. 36.
    McIntosh C, Pederson RA, Koop H, Brown JC 1981 Gastric inhibitory polypeptide stimulated secretion of somatostatin-like immunoreactivity from the stomach, inhibition by acetylcholine or vagal stimulation. Can J Physiol Pharmacol 59: 468.PubMedGoogle Scholar
  37. 37.
    Chiba T, Kadowaki S, Taminato T, Kodama H, Chihara K, Seino Y, Fujita T 1983 Effects of acetylcholine and vagal stimulation on somatostatin and gastrin release from isolated perfused rat stomach. Regul Peptides (Suppl 2 ): S2.CrossRefGoogle Scholar
  38. 38.
    Lefebvre PJ, Luyckx AS 1980 Extrapancreatic glucagon: experimental studies using the isolated perfused dog stomach. In Andreani D, Lefebvre PJ, Marks V (eds) Current Views on Hypoglycemia and Glucagon. Academic Press, London, p 27.Google Scholar
  39. 39.
    Uvnas-Wallensten K, Efendic S, Roovete A, Johansson C 1980 Decreased release of somatostatin into the portal vein following electrical vagal stimulation in the cat. Acta Physiol Scand 109: 393.PubMedCrossRefGoogle Scholar
  40. 40.
    Guzman S, Chayvialle JA, Banks WA, Rayford PL, Thompson JC 1979 Effect of vagal stimulation on pancreatic secretion and blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide and somatostatin. Surgery 86: 329.PubMedGoogle Scholar
  41. 41.
    Holst JJ 1982 Neural control of the pancreas. In:Bloom SR, Polak JM, Lindenlaub E (eds) Systemic Role of Regulatory Peptides. Schattauer, Stuttgart, p 171.Google Scholar
  42. 42.
    Schusdziarra V, Stapelfeldt W, Klier M, Pfeiffer EF 1981 Effect of acetylcholine upon the release of pancreatic and gastric somatostatin-like immunoreactivity treated dogs. HepatoGastroenterol 29: 153.Google Scholar
  43. 43.
    Lucey MR, Wass JAH, Fairclough PD, Penman E, Rees LH 1983 Autonomic control of postprandial plasma somatostatin release in man. Gastroenterology 84: 61.Google Scholar
  44. 44.
    Holst JJ, Jensen SL, Knuhtsen S, Nielsen OV 1983 Autonomic nervous control of pancreatic somatostatin secretion. Am J Physiol 245: E542.PubMedGoogle Scholar
  45. 45.
    Samols E, Weir GC, Ramseur R, Day JA, Patel YC 1978 Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper-and hypoglycemic sulfonamides. Metabolism 27 (Suppl 1): 1219.PubMedCrossRefGoogle Scholar
  46. 46.
    Hermansen K, Christensen SE, Orskov H 1977 Characterization of somatostatin release from the pancreas. The role of calcium and acetylcholine. Diabetologia 16: 261.Google Scholar
  47. 47.
    Wasada T, Dobbs RE, Harris V, Unger RH 1981 Effect of 2-deoxyD-glucose on plasma somatostatin levels in conscious dogs. Endocrinology 108: 1222.PubMedCrossRefGoogle Scholar
  48. 48.
    Schusdziarra V, Bender H, Pfeiffer EF 1983 Release of bombesinlike immunoreactivity from the isolated perfused rat stomach. Regul Peptides 7: 21.CrossRefGoogle Scholar
  49. 49.
    Kaneto A, Kawazum S, Sato H, Kaneko T, Yanaihara C, Yanaihara N, Kosaka K 1981 Effect of the vagal and splanchnic nerve stimulation on the release of somatostatin, pancreatic polypeptide, glucagon and insulin. Biomed Res 2: 166.Google Scholar
  50. 50.
    Kaneto A, Sato H, Kaneko T, Yanaihara C, Yanaihara N, Kosaka K 1981 Stimulation of somatostatin, pancreatic polypeptide, glucagon and insulin secretion by acetylcholine infused intrapancreatically in dogs. Biomed Res 2: 57.Google Scholar
  51. 51.
    Schusdziarra V, Rouiller D, Harris V, Dey R, Unger RH 1980 Plasma somatostatin-like immunoreactivity in chemically sympathectomized dogs. Horm Metab Res 12: 656.PubMedCrossRefGoogle Scholar
  52. 52.
    Rouiller D, Schusdziarra V, Harris V, Unger RH 1980 Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin, gastric inhibitory polypeptide and gastrin-17 in dogs. Endocrinology 107: 524.PubMedCrossRefGoogle Scholar
  53. 53.
    Guzman S, Lonovics J, Chayvialle JA, Hejtmancik KE, Rayford PL, Thompson JC 1980 Effects of gastrin on circulating levels of somatostatin, pancreatic polypeptide and vasoactive intestinal peptide in dogs. Endocrinology 107: 231.PubMedCrossRefGoogle Scholar
  54. 54.
    Schusdziarra V, Rewes B, Lenz N, Maier V, Pfeiffer EF 1983 Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function. Regul Peptides 7: 243.CrossRefGoogle Scholar
  55. 55.
    Schusdziarra V, Holland A, Maier V, Pfeiffer EF 1984 Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals. Peptides 5: 65.PubMedCrossRefGoogle Scholar
  56. 56.
    Schusdziarra V, Schick R, de la Fuente A, Holland A, Brantl V, Pfeiffer EF 1983 Effect of ß -casomorphins on somatostatin release in dogs. Endocrinology 6: 1948.CrossRefGoogle Scholar
  57. 57.
    Schusdziarra V, Rouiller D, Harris V, Unger RH 1981 Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of a meal. Regul Peptides 2: 353.CrossRefGoogle Scholar
  58. 58.
    Schusdziarra V, Stapelfeldt W, Klier M, Maier V, Pfeiffer EF 1982 Effect of histamine H2-receptor stimulation on postprandial pancreatic and gastric endocrine function in dogs. Res Exp Med 181: 253.CrossRefGoogle Scholar
  59. 59.
    Schusdziarra V, Rouiller D, Jaffe BM, Harris V, Unger RH 1980 Effect of exogenous and endogenous prostaglandin E upon gastric endocrine function in dogs. Endocrinology 106: 1620.Google Scholar
  60. 60.
    Saffouri B, Weir GC, Bitar KN, Ifakhlouf GM 1980 Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol 238: 495.Google Scholar
  61. 61.
    Schusdziarra V, Rouiller D, Harris V, Wasada T, Unger RH 1981 Effect of prostaglandin E2 upon release of pancreatic somatostatin-like immunoreactivity. Life Sci 28: 2099.PubMedCrossRefGoogle Scholar
  62. 62.
    Takemura J, Seino Y, Nishi S, Ishida H, Sakita M, Taminato T, Chiba T, Imura H 1983 Effects of prostaglandin E2 and D2 on gastric somatostatin and gastric secretion. Regul Peptides 6: 379.CrossRefGoogle Scholar
  63. 63.
    Schusdziarra V, Bender H, Pfeffer A, Kaminska D, Pfeiffer EF 1984 Effect of indomethacin on bombesin-like immunoreactivity, somatostatin and gastrin secretion from rat stomach, submitted for publication.Google Scholar
  64. 64.
    Pelletier G 1977 Identification of four cell types in the human endocrine pancreas by immunoelectron microscopy. Diabetes 26: 749.PubMedCrossRefGoogle Scholar
  65. 65.
    Schatz H, Kullek U 1980 Studies on the local (paracrine) actions of glucagon, somatostatin and insulin in isolated islets or rat pancreas. Febs Lett 122: 207.PubMedCrossRefGoogle Scholar
  66. 66.
    Trimble ER, Berthoud HR, Siegel EG, Jeanrenaud B, Renold AR 1981 Importance of cholinergic innervation of the pancreas for glucose tolerance in the rat. Am J Physiol 241: 337.Google Scholar
  67. 67.
    Arimura A, Meyers CA, Case WL, Murphy WA, Schally AV 1979 Suppression of somatostatin levels in the hepatic portal and systemic plasma of the rat by synthetic human pancreatic polypeptide. Biochem Biophys Res Commun 89: 913.PubMedCrossRefGoogle Scholar
  68. 68.
    Ipp E, Rivier J, Dobbs RE, Brown M, Vale W, Unger RH 1979 Somatostatin analogs inhibit somatostatin release. Endocrinology 104: 1270.PubMedCrossRefGoogle Scholar
  69. 69.
    Patel YC, Weir GC 1976 Increased somatostatin content of islets from streptozotocin diabetic rats. Clin Endocrinol 5: 191.CrossRefGoogle Scholar
  70. 70.
    Kadowaki S, Taminato T, Chiba T, Nori K, Abe H, Goto Y, Seino Y, Matsukara S, Nozawa M, Fujita T 1979 Somatostatin release from isolated perfused rat pancreas. Possible role of endogenous somatostatin on insulin release. Diabetes 28: 600.Google Scholar
  71. 71.
    Patel YC, Amherdt M, Orci L 1979 Somatostatin secretion from monolayer cultures of neonatal rat pancreas. Endocrinology 104: 676.PubMedCrossRefGoogle Scholar
  72. 72.
    Weir GC, Samols E, Loo S, Patel YC, Gabbay KH 1979 Somatostatin and pancreatic polypeptide secretion. Effects of glucagon, insulin and arginine. Diabetes 28: 35.Google Scholar
  73. 73.
    Gerber PG, Trimble ER, Wollheim GC, Renold AE 1981 Effect of insulin on glucose and arginine-stimulated somatostatin secretion from isolated perfused rat pancreas. Endocrinology 109: 279.PubMedCrossRefGoogle Scholar
  74. 74.
    Rothman J, Ignarro LJ 1978 Effect of anti-insulin serum on pancreatic somatostatin release. Clin Res 26: 775A.Google Scholar
  75. 75.
    Wass JAR, Penman E, Medbak S, Dawson AM, Tsiolakis D, Marks V, Besser GM, Rees LH 1980 Immunoreactive somatostatin changes during insulin-induced hypoglycemia and operative stress in man. Clin Endocrinol 12: 269.CrossRefGoogle Scholar
  76. 76.
    Schusdziarra V, Dobbs RE, Harris V, Unger RH 1977 Inimunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. Febs Lett 81: 69.PubMedCrossRefGoogle Scholar
  77. 77.
    Wasada T, Howard B, Dobbs R, Unger RH 1980 Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs. J Clin Invest 66: 511.PubMedCrossRefGoogle Scholar
  78. 78.
    Hermansen K 1982 Stimulatory effect of ß-hydroxybutyrate on the release of somatostatin from the isolated pancreas of normal and streptozotocin-diabetic dogs. Diabetes 31: 270.PubMedCrossRefGoogle Scholar
  79. 79.
    Rouiller D, Schusdziarra V, Unger RH 1981 Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HC1. Diabetes 30: 735.PubMedCrossRefGoogle Scholar
  80. 80.
    Glaser B, Vinik AJ, Valtysson G, Zoghlin G 1981 Truncal vagotomy abolishes the somatostatin response to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 52: 823.PubMedCrossRefGoogle Scholar
  81. 81.
    Webb S, Levy I, Wass JAH, Lorens A, Penman E, Casamitjama R, Wu P, Gaya J, Martinez MJ, Rivera F 1983 Insulin induced somatostatin secretion in man is mediated by gastric acid. Regul Peptides (Suppl 2 ): S11.CrossRefGoogle Scholar
  82. 82.
    Patton GS, Ipp E, Dobbs RE, Vale W, Orci L, Unger RH 1976 Response of pancreatic-immunoreactive somatostatin to arginine. Life Sci 19: 1957.PubMedCrossRefGoogle Scholar
  83. 83.
    Schauder P, McIntosh C, Arends G, Arnold R, Frerichs H, Creutzfeldt W 1976 Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. Febs Lett 68: 255.CrossRefGoogle Scholar
  84. 84.
    Schauder P, McIntosh C, Arends J, Arnold R, Frerichs H, Creutzfeldt W 1977 Somatostatin and insulin release from isolated rat pancreatic islets in responses to D-glucose, L-leucine, o-ketoisocaproic acid or D-glyceraldehyde: evidence for a regulatory role of adenosine 3’-5’ cyclic monophosphate. Biochem Biophys Res Commun 75: 630.PubMedCrossRefGoogle Scholar
  85. 85.
    Schauder P, McIntosh C, Panten V, Arends J, Frerichs H, Creutzfeldt W 1977 Dynamics of somatostatin release from isolated rat pancreatic islets. Febs Lett 81: 355.PubMedCrossRefGoogle Scholar
  86. 86.
    Ipp E, Dobbs RE, Arimura A, Vale W, Harris V, Unger RH 1977 Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin and tolbutamide. J Clin Invest 60: 760.PubMedCrossRefGoogle Scholar
  87. 87.
    Schusdziarra V, Harris V, Arimura A, Unger RH 1979 Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 104: 1705.PubMedCrossRefGoogle Scholar
  88. 88.
    Schusdziarra V, Stapelfeldt W, Klier M, Maier V, Pfeiffer EF 1981 Effect of physiological increments of blood glucose on plasma somatostatin and pancreatic polypeptide levels in dogs. Regul Peptides 2: 211.CrossRefGoogle Scholar
  89. 89.
    Schusdziarra V 1980 Somatostatin - a regulatory modulator connecting nutrient entry and metabolism. Horm Metab Res 12: 563.PubMedCrossRefGoogle Scholar
  90. 90.
    McIntosh C, Arnold R 1978 The radioimmunoassay and physiology of somatostatin in the pancreas and gastrointestinal tract. Zschr Gastroenterol 16: 330.Google Scholar
  91. 91.
    Patel YC, Zingg HH, Fitzpatrick D, Srikant CB 1981 Somatostatin: some aspects of its physiology and pathophysiology. In: Bloom SR, Polak JM (eds) Gut Hormones, Churchill Livingstone, p 339.Google Scholar
  92. 92.
    Arimura A, Fishback JB 1981 Somatostatin: Regulation of secretion. Neuroendocrinology 33: 246.Google Scholar
  93. 93.
    Kawai K, Ipp E, Orci L, Perrelet A, Unger RH 1982 Circulating somatostatin acts on the islets of Langerhans by way of somatostatin-poor compartment. Science 218: 477.PubMedCrossRefGoogle Scholar
  94. 94.
    Schusdziarra V, Rouiller D, Arimura A, Unger RH 1979 Antisomatostatin serum increases levels of hormones from the pituitary and gut but not from the pancreas. Endocrinology 103: 1956.CrossRefGoogle Scholar
  95. 95.
    Schusdziarra V, Zyznar E, Rouiller D, Boden G, Brown JC, Arimura A, Unger RH 1980 Splanchnic somatostatin: A hormonal regulator of nutrient homeostasis. Science 207: 530.Google Scholar
  96. 96.
    Vaysse N, Chayvialle JA, Pradayrol L, Esteve JR, Susimi C, Lapuelle J, Descos F, Ribet A 1981 Somatostatin 28: Comparison with somatostatin-14 for plasma kinetics and low-dose effects on the exocrine pancreas in dogs. Gastroenterology 81: 700.PubMedGoogle Scholar
  97. 97.
    Uvnas-Wallensten K, Efendic S, Johansson C, Sjodin L, Cranwell PD 1981 Effect of intra-antral and intrabulbar pH on somatostatin-like immunoreactivity in peripheral venous blood of conscious dogs. The possible function of somatostatin as an inhibitory hormone of gastric acid secretion and its possible identity with bulbogastrone and antral chalone. Acta Physiol Scand 111: 397.Google Scholar
  98. 98.
    Aizawa I, Itoh Z, Harris V, Unger RH 1981 Plasma somatostatinlike immunoreactivity during the interdigestive period in the dog. J Clin Invest 68: 206.PubMedCrossRefGoogle Scholar
  99. 99.
    Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T, Yanase E, Kawato M, Hiraiwa Y, Sakato S, Takeda R 1981 Effect of somatostatin on flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 30: 440.PubMedGoogle Scholar
  100. 100.
    Johansson C, Kollberg B, Efendic S, Uvnas-Wallensten K 1981 Effects of graded doses of somatostatin on gallbladder emptying and pancreatic enzyme putput after oral glucose in man. Digestion 22: 24.PubMedCrossRefGoogle Scholar
  101. 101.
    Johansson C, Visen O, Efendic S, Uvnas-Wallensten K 1981 Effect on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22: 126.PubMedCrossRefGoogle Scholar
  102. 102.
    Zyznar E, Pietri A, Harris V, Unger RH 1981 Evidence for the hormonal status of somatostatin in man. Diabetes 30: 883.PubMedCrossRefGoogle Scholar
  103. 103.
    Feurle GE, Spoleanschi P, Stander M, Klempa I 1982 Dose-response study of somatostatin meal-stimulated levels of pancreatic polypolypeptide and insulin in the dog. Digestion 23: 119.PubMedCrossRefGoogle Scholar
  104. 104.
    Souquet JC, Rambliere R, Riou JP, Beylot M, Cohen R, Mornex R, Chayvialle JA 1983 Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin-14. J Clin Endocrinol Metab 56: 1076.PubMedCrossRefGoogle Scholar
  105. 105.
    Colturi TJ, Unger RH, Peters M, Feldman M 1983 Physiologic role for circulating somatostatin in gastric secretion in man. Gastroenterology 84: 60.Google Scholar
  106. 106.
    Patel YC, Orci L, Bankier A, Cameron DP 1976 Decreased pancreatic somatostatin concentration in spontaneously diabetic mice. Endocrinology 99: 1415.PubMedCrossRefGoogle Scholar
  107. 107.
    Patel YC, Cameron DP, Stefan YC, Malaisse-Lagae F, Orci L 1977 Somatostatin: Widespread abnormality in tissues of spontaneously diabetic mice. Science 198: 930.Google Scholar
  108. 108.
    Berelowitz M, Coleman DL, Frohman LA 1980 Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice. Diabetes 29: 717.PubMedCrossRefGoogle Scholar
  109. 109.
    Trimble ER, Herberg L, Renold AE 1980 Hypersecretion of pancreatic somatostatin in the obese Zucker rat. Diabetes 29: 889.PubMedCrossRefGoogle Scholar
  110. 110.
    Goto Y, Carpenter RG, Berelowitz M, Frohman LA 1980 Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas. Metabolism 29: 986.PubMedCrossRefGoogle Scholar
  111. 111.
    Seino Y, Seino S, Katemura J, Tsuda K, Nishi S, Ishida H, Seno M, Usami M, Ikeda M, Imura H 1984 Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats. Endocrinology 114: 457.PubMedCrossRefGoogle Scholar
  112. 112.
    Seino S, Seino Y, Takemura J, Tsuda K, Kuzya H, Ishikawa K, Shimazu T, Imura H 1981 Somatostatin, insulin and glucagon secretion from isolated perfused pancreas of obese rats. Am J Physiol 241: 146.Google Scholar
  113. 113.
    Seino S, Seino Y, Sakurai H, Takemura J, Kuzuya H, Imura H, Ishikawa K, Shimazu T, Usami M, Ideda M 1981 The effect of ventromedial hypothalamic nuclei destruction on somatostatin and insulin release from the isolated perfused rat pancreas. Life Sci 28: 2231.PubMedCrossRefGoogle Scholar
  114. 114.
    Sheppard MC, Shapiro B, Hudson A, Pimstone BL 1980 Tissue and serum somatostatin-like immunoreactivity in lean and obese Zucker rats. Horm Metab Res 12: 236.PubMedCrossRefGoogle Scholar
  115. 115.
    Boden G, Baffle CA, McLaughlin CL, Matschinsky FM 1981 Effects of starvation and obesity on somatostatin, insulin and glucagon release from an isolated perfused organ system. Am J Physiol 241: E215.PubMedGoogle Scholar
  116. 116.
    Tsuda K, Seino Y, Seino S, Takemura J, Kuzuya H, Chiba T, Imura H 1981 Effect of starvation on gastric somatostatin release. Life Sci 29: 27.PubMedCrossRefGoogle Scholar
  117. 117.
    Koop H, Schwab E, Arnold R, Creutzfeld W 1982 Effect of food deprivation on rat gastric somatostatin and gastric release. Gastroenterology 82: 871.PubMedGoogle Scholar
  118. 118.
    Voyles NR, Awoke S, Wade A, Bhathena SJ, Smith SS, Recant L 1982 Starvation increases gatrointestinal somatostatin in normal and obese Zucker rats: A possible regulatory mechanism. Horm Metab Res 14: 392.Google Scholar
  119. 119.
    Tanigawa K, Kuzuya H, Seino Y, Seino S, Tsuda K, Sakurai H, Imura H 1982 Effect of starvation on somatostatin content of pancreas and gatrointestinal tract of the guinea pig. Horm Metab Res 14: 245.PubMedCrossRefGoogle Scholar
  120. 120.
    Martin RJ, Gahagan J 1977 Serum hormone levels and tissue metabolism in pair-fed lean and obese Zucker rats. Horm Metab Res 9: 181.PubMedCrossRefGoogle Scholar
  121. 121.
    Bender H, Schusdziarra V, Pfeiffer EF 1984 Increased sensitivity to somatostatin in obese Zucker rats. Clin Physiol Biochem. (in press).Google Scholar
  122. 122.
    Schusdziarra V, Lawecki J, Ditschuneit HH, Lukas B 1984 Hyposomatostatinemia and increased sensitivity to synthetic somatostatin in obesity. Acta Endocrinol 105 (Suppl 264): 27.Google Scholar
  123. 123.
    Sasaki H, Nagulesparan M, Dubois A, Vesquez B, Johnson GC, Sievers ML, Unger RH 1983 Hyperinsulinemia in obesity: Lack of relation to gastric emptying of glucose solution or to plasma somatostatin levels. Metab Clin Exp 32: 701.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • V. Schusdziarra
    • 1
  1. 1.Department of Internal Medicine IUniversity of UlmUlm/DonauGermany

Personalised recommendations